The U.S. Department of Commerce, International Trade Administration and U.S. and Foreign Commercial Service have announced an October 29-November 2, 2012, Biotech Life Sciences trade mission to Australia. Participants are expected to include a variety of U.S. biotechnology and life science firm representatives who will visit prominent biotech organizations, attend government meetings and participate in briefings and receptions during Melbourne’s AusBiotech National Conference, which purportedly attracts biotech companies in the medical, diagnostics, agriculture, industrial, and environmental sectors.

The trade mission’s goals are to (i) “increase U.S. exports to Australia,” (ii) “introduce U.S. participants to potential strategic partners,” (iii) “introduce U.S. participants to industry and government officials in Australia to learn about various opportunities,” and (iv) “educate the participants about trade policy and regulatory matters involved in doing business in Australia.” Applications for the mission must be submitted by July 15, 2012, and selection decisions will be made on a rolling basis until 10 to 12 participants have been selected. See Federal Register, June 13, 2012.